A feasibility study of capecitabine and oxaliplatin (XELOX) for patients with stage II/III colon cancer.
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2623439
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: XELOX Capecitabine:2000mg/m2 d1-14 Oxaliplatin:130mg/m2 d1 Q3w
Primary outcome(s): Completion rate of treatment
Study Design: Single arm Non-randomized
创建时间：
2012-06-15
